Seminars in Nuclear Medicine
Volume 37, Issue 6 , Pages 440-450, November 2007

3,4-Dihydroxy-6-[18F]-Fluoro-L-Phenylalanine Positron Emission Tomography in Patients With Central Motor Disorders and in Evaluation of Brain and Other Tumors

  • John P. Seibyl, MD
    • ,
  • Wei Chen, MD, PhD
    • ,
  • Daniel H.S. Silverman, MD, PhD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Daniel H.S. Silverman, MD, PhD, Ahmanson Biological Imaging Division, UCLA Medical Center, CHS AR-144, MC694215, Los Angeles, CA 90095-6942.

Ahmanson Biological Imaging Division, UCLA Medical Center, Los Angeles, CA.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0001-2998(07)00088-8

doi:10.1053/j.semnuclmed.2007.08.002

Seminars in Nuclear Medicine
Volume 37, Issue 6 , Pages 440-450, November 2007

Article Tools

* Image Usage & Resolution